CNR Institutional Research Information System

MANCA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.353
NA - Nord America 1.258
EU - Europa 690
SA - Sud America 380
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 40
OC - Oceania 5
Totale 4.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.188
SG - Singapore 965
CN - Cina 455
BR - Brasile 309
IT - Italia 275
HK - Hong Kong 247
VN - Vietnam 220
BD - Bangladesh 155
FR - Francia 119
JP - Giappone 100
NL - Olanda 99
KR - Corea 65
DE - Germania 49
IN - India 46
GB - Regno Unito 38
CA - Canada 33
AR - Argentina 26
FI - Finlandia 22
MX - Messico 19
ID - Indonesia 18
ZA - Sudafrica 15
AT - Austria 14
IE - Irlanda 13
IL - Israele 12
IQ - Iraq 12
EC - Ecuador 10
ES - Italia 9
PL - Polonia 9
VE - Venezuela 9
CO - Colombia 8
PH - Filippine 8
SA - Arabia Saudita 8
UY - Uruguay 7
KE - Kenya 6
RU - Federazione Russa 6
TR - Turchia 6
MA - Marocco 5
PY - Paraguay 5
UZ - Uzbekistan 5
DZ - Algeria 4
HN - Honduras 4
JM - Giamaica 4
KZ - Kazakistan 4
PE - Perù 4
PK - Pakistan 4
AU - Australia 3
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
NP - Nepal 3
OM - Oman 3
SE - Svezia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.726
Salva come PNG Salva come JPEG
Città #
Singapore 530
Santa Clara 298
Hong Kong 245
San Jose 151
Hefei 137
Ashburn 116
Lauterbourg 96
Beijing 93
Tokyo 87
Ho Chi Minh City 76
Los Angeles 65
Hanoi 64
Seoul 62
Dallas 47
New York 30
São Paulo 26
Cavallino 22
Rome 19
Milan 18
Cagliari 17
Amsterdam 15
Buffalo 14
Guangzhou 14
Council Bluffs 13
Dublin 13
Frankfurt am Main 12
Helsinki 11
Naples 11
Orem 11
Rio de Janeiro 11
Düsseldorf 10
Genoa 10
Montreal 10
Munich 10
Vienna 10
Boardman 9
Minamishinagawa 9
Phoenix 9
Brooklyn 8
Toronto 8
Turku 8
Florence 7
Johannesburg 7
Nuremberg 7
Sala Baganza 7
Assemini 6
Belo Horizonte 6
Bengaluru 6
Boston 6
Campinas 6
Chennai 6
Chicago 6
Da Nang 6
Hải Dương 6
Jakarta 6
Manchester 6
Montevideo 6
Mumbai 6
Nairobi 6
Porto Alegre 6
Thái Nguyên 6
Atlanta 5
Bari 5
Curitiba 5
Denver 5
Houston 5
Maceió 5
Philadelphia 5
Sassari 5
Seattle 5
Tashkent 5
Warsaw 5
Baghdad 4
Biên Hòa 4
Elk Grove Village 4
Guayaquil 4
Haiphong 4
Hyderabad 4
Inglewood 4
Las Vegas 4
London 4
Newark 4
Quận Một 4
Recife 4
Riyadh 4
Salvador 4
The Bronx 4
Uberlândia 4
Brescia 3
Buenos Aires 3
Cape Town 3
Carapicuíba 3
Dhaka 3
El Centro 3
Franca 3
Goiânia 3
Greensboro 3
Guarulhos 3
Ha Long 3
Hendersonville 3
Totale 2.704
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 122
Idiopathic pulmonary fibrosis (IPF) and lung cancer 108
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 94
Il CSCC: aspetti distintivi della patologia 82
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 81
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 77
Germline and somatic NGS-based analysis on BRCA-related tumors 76
Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the “AMICA” project 74
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 70
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 70
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 68
Genetic alterations in main candidate genes during melanoma progression. 67
Phenotype characterization of human melanoma cells resistant to Dabrafenib 67
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 67
nalysis of Fanconi anemia genes in colorectal cancer. 66
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 65
Molecular Basis of open-angle glaucoma in Italy 64
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 64
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 64
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 64
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 63
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
Genetic Instability Markers in Cancer 60
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 58
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 57
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 56
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 52
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 52
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 52
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 51
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 50
Ngs-based analysis of atypical deep penetrating nevi 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Origin of aneuploidy in relation to disturbances of cell-cycle progression. I. Effects of vinblastine on mouse bone marrow cells 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 49
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 47
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 44
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 43
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 43
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome 42
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 42
Proteomic analysis in melanoma cell lines with different genotypes 41
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 41
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 40
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 39
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 38
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 37
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 36
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 36
Proteomic Profiling of Human Melanoma Metastatic Cell Line Secretomes 35
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 35
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 34
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 34
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 34
Long non-coding RNA CASC2 in human cancer 34
Molecular basis of open-angle glaucoma in Italy 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 32
Low prevalence of microsatellite instability in malignant melanoma. 31
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 31
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 31
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 31
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
Assesment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 30
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 30
Genetic alterations in main candidate genes during melanoma progression 30
Detailed physical analysis of a 1.5-megabase YAC contig containing the MXI1 and ADRA2A genes 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 29
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 29
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 28
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 27
Epidemiological and genetic factors underlying melanoma development in Italy 27
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases 27
Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad 27
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 27
Fragile X syndrome without CCG amplification has an FMR1 deletion 27
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 27
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 26
Discrepant alterations in main candidate genes among multiple primary melanomas 26
Downregulation of the CASC2a gene in endometrial cancer. 26
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
How to treat BRAF mutant metastatic melanoma? 26
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 25
Assessment of the progressive alterations in hepathic tumorigenesis through metabolic analysis. 25
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
MUTATIONS IN ERBB4 MAY PLAY A MINOR ROLE IN MELANOMA PATHOGENESIS 25
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 25
Proteomics and expression analysis for identification of new candidate genes in melanoma progression 24
A strategy for the selection of transcribed sequences in the Xq28 region 24
TRANSGENIC MOUSE - AN INVIVO SYSTEM FOR DETECTION OF ANEUGENS 24
Role of CASC2 a gene in human endometrial cancer. 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Role on the BRAF gene in malignant melanoma 24
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 23
Totale 4.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.785
article - articoli 13.011
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 796
Totale 30.592
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 5 0 15 8
2024/20251.631 17 6 98 64 294 77 29 98 66 100 382 400
2025/20262.987 137 201 261 337 512 124 476 174 207 185 167 206
2026/2027188 186 2 0 0 0 0 0 0 0 0 0 0
Totale 4.834